查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物可吸收血管支架市場（產品類型：Everolimus洗脫設備、Novolimus洗脫設備、Sirolimus洗脫設備和其他） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1301437

生物可吸收血管支架市場（產品類型：Everolimus洗脫設備、Novolimus洗脫設備、Sirolimus洗脫設備和其他） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 228 Pages | 商品交期: 2-10個工作天內

價格

生物可吸收血管支架市場- 報告範圍

TMR關於全球生物可吸收血管支架市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球生物可吸收血管支架市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球生物可吸收血管支架市場的複合年成長率（CAGR %）。

該報告是在廣泛研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解生物可吸收血管支架市場。

該報告深入研究了全球生物可吸收血管支架市場的競爭格局。在全球生物可吸收血管支架市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、近期發展和SWOT是本報告對全球生物可吸收血管支架市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 產品定義
    • 行業演變/發展
  • 市場概況
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析和預測

第五章：關鍵洞察力

  • 技術進步
  • 疾病發生率和流行率
  • 法規分析
  • COVID-19的影響分析

第六章：全球市場分析和預測：按產品類型分類

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按產品類型，2017 - 2031年
    • 依維莫司洗脫裝置
    • 諾和力木斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場吸引力分析：按產品類型

第七章：全球市場分析和預測：按疾病類型分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按疾病類型，2017-2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場吸引力分析：按疾病類型

第八章：全球市場分析與預測：按材料類型分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場吸引力分析：按材料類型

第九章：全球市場分析與預測：按終端用戶分類

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構等）。
  • 市場吸引力分析：按終端用戶

第十章：全球市場分析與預測：按地區分類

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第11章：北美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品類型，2017-2031年
    • 依佛利木斯洗脫裝置
    • 諾利木斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場價值預測：按疾病類型，2017 - 2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構，等）
  • 市場價值預測：按國家分類，2017 - 2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品類型
    • 按疾病類型分類
    • 按材料類型
    • 按終端用戶分類
    • 按國家分類

第12章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品類型，2017 - 2031年
    • 依佛利木斯洗脫裝置
    • 諾和力莫斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場價值預測：按疾病類型，2017 - 2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構，等）
  • 市場價值預測：按國家/次區域，2017 - 2031年
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病類型分類
    • 按材料類型
    • 按終端用戶分類
    • 按國家/次區域分類

第13章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品類型，2017 - 2031年
    • 依佛利木斯洗脫裝置
    • 諾和力莫斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場價值預測：按疾病類型，2017 - 2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構，等）
  • 市場價值預測：按國家/次區域，2017 - 2031年
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病類型分類
    • 按材料類型
    • 按終端用戶
    • 按國家/次區域分類

第十四章：拉丁美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品類型，2017 - 2031年
    • 依佛利木斯洗脫裝置
    • 諾和力莫斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場價值預測：按疾病類型，2017 - 2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構，等）
  • 市場價值預測：按國家/次區域，2017 - 2031年
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病類型分類
    • 按材料類型
    • 按終端用戶
    • 按國家/次區域分類

第15章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品類型，2017 - 2031年
    • 依佛利木斯洗脫裝置
    • 諾和力莫斯洗脫裝置
    • 西羅莫司洗脫裝置
    • 其他（雷帕黴素等）。
  • 市場價值預測：按疾病類型，2017 - 2031年
    • 冠狀動脈疾病
    • 周邊動脈疾病
  • 市場價值預測：按材料類型，2017 - 2031年
    • 聚L-乳酸（PLLA）
    • 酪氨酸衍生的聚碳酸酯
    • 其他（聚二氧六環酮，等）
  • 市場價值預測：按終端用戶，2017 - 2031年
    • 醫院
    • 非住院手術中心
    • 心肌梗塞實驗室
    • 其他（研究機構，等）
  • 市場價值預測：按國家/次區域，2017 - 2031年
    • 海灣合作理事會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病類型分類
    • 按材料類型
    • 按終端用戶分類
    • 按國家/次區域分類

第16章：競爭格局

  • 市場參與者- 競爭矩陣（按公司的層級和規模分類）
  • 按公司分類的市場佔有率分析（2021年）
  • 公司簡介
    • Kyoto Medical Planning Co., Ltd.
    • BIOTRONIK Group of Companies
    • REVA Medical
    • Elixir Medical
    • Arterius
    • Meril Life Sciences Pvt. Ltd
    • S3V Vascular Technologies
    • Zorion medical
    • Medtronic (development phase)
Product Code: TMRGL32003

Bioresorbable Vascular Scaffold Market - Scope of Report

TMR's report on the global Bioresorbable Vascular Scaffold market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Bioresorbable Vascular Scaffold market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Bioresorbable Vascular Scaffold market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Bioresorbable Vascular Scaffold market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Bioresorbable Vascular Scaffold market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Bioresorbable Vascular Scaffold market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Bioresorbable Vascular Scaffold market.

The report delves into the competitive landscape of the global Bioresorbable Vascular Scaffold market. Key players operating in the global Bioresorbable Vascular Scaffold market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Bioresorbable Vascular Scaffold market profiled in this report.

Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report:

  • What is the sales/revenue generated by Bioresorbable Vascular Scaffold across all regions during the forecast period?
  • What are the opportunities in the global Bioresorbable Vascular Scaffold market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bioresorbable Vascular Scaffold Market - Research Objectives and Research Approach

The comprehensive report on the global Bioresorbable Vascular Scaffold market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Bioresorbable Vascular Scaffold market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Bioresorbable Vascular Scaffold market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioresorbable Vascular Scaffold Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Development
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, 2017 - 2031

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Disease Incidence and Prevalence
  • 5.3. Regulatory Analysis
  • 5.4. COVID-19 Impact Analysis

6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017 - 2031
    • 6.3.1. Everolimus-eluting Device
    • 6.3.2. Novolimus-eluting Device
    • 6.3.3. Sirolimus-eluting Device
    • 6.3.4. Others (Rapamycin, etc.)
  • 6.4. Market Attractiveness Analysis, By Product Type

7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 7.3.1. Coronary Artery Disease
    • 7.3.2. Peripheral Artery Disease
  • 7.4. Market Attractiveness Analysis, By Disease Type

8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Material Type, 2017 - 2031
    • 8.3.1. Poly-L-Lactic Acid (PLLA)
    • 8.3.2. Tyrosine-derived Polycarbonate
    • 8.3.3. Others (Polydioxanone, etc.)
  • 8.4. Market Attractiveness Analysis, By Material Type

9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017 - 2031
    • 9.3.1. Hospital
    • 9.3.2. Ambulatory Surgical Center
    • 9.3.3. Cardiac Catheterization Lab
    • 9.3.4. Others (Research Institute, etc.)
  • 9.4. Market Attractiveness Analysis, By End-user

10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, By Region

11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 11.2.1. Everolimus-eluting Device
    • 11.2.2. Novolimus-eluting Device
    • 11.2.3. Sirolimus-eluting Device
    • 11.2.4. Others (Rapamycin, etc.)
  • 11.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 11.3.1. Coronary Artery Disease
    • 11.3.2. Peripheral Artery Disease
  • 11.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 11.4.1. Poly-L-Lactic Acid (PLLA)
    • 11.4.2. Tyrosine-derived Polycarbonate
    • 11.4.3. Others (Polydioxanone, etc.)
  • 11.5. Market Value Forecast, by End-user, 2017 - 2031
    • 11.5.1. Hospital
    • 11.5.2. Ambulatory Surgical Center
    • 11.5.3. Cardiac Catheterization Lab
    • 11.5.4. Others (Research Institute, etc.)
  • 11.6. Market Value Forecast, by Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Disease Type
    • 11.7.3. By Material Type
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 12.2.1. Everolimus-eluting Device
    • 12.2.2. Novolimus-eluting Device
    • 12.2.3. Sirolimus-eluting Device
    • 12.2.4. Others (Rapamycin, etc.)
  • 12.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 12.3.1. Coronary Artery Disease
    • 12.3.2. Peripheral Artery Disease
  • 12.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 12.4.1. Poly-L-Lactic Acid (PLLA)
    • 12.4.2. Tyrosine-derived Polycarbonate
    • 12.4.3. Others (Polydioxanone, etc.)
  • 12.5. Market Value Forecast, by End-user, 2017 - 2031
    • 12.5.1. Hospital
    • 12.5.2. Ambulatory Surgical Center
    • 12.5.3. Cardiac Catheterization Lab
    • 12.5.4. Others (Research Institute, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Disease Type
    • 12.7.3. By Material Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 13.2.1. Everolimus-eluting Device
    • 13.2.2. Novolimus-eluting Device
    • 13.2.3. Sirolimus-eluting Device
    • 13.2.4. Others (Rapamycin, etc.)
  • 13.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 13.3.1. Coronary Artery Disease
    • 13.3.2. Peripheral Artery Disease
  • 13.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 13.4.1. Poly-L-Lactic Acid (PLLA)
    • 13.4.2. Tyrosine-derived Polycarbonate
    • 13.4.3. Others (Polydioxanone, etc.)
  • 13.5. Market Value Forecast, by End-user, 2017 - 2031
    • 13.5.1. Hospital
    • 13.5.2. Ambulatory Surgical Center
    • 13.5.3. Cardiac Catheterization Lab
    • 13.5.4. Others (Research Institute, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Disease Type
    • 13.7.3. By Material Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 14.2.1. Everolimus-eluting Device
    • 14.2.2. Novolimus-eluting Device
    • 14.2.3. Sirolimus-eluting Device
    • 14.2.4. Others (Rapamycin, etc.)
  • 14.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 14.3.1. Coronary Artery Disease
    • 14.3.2. Peripheral Artery Disease
  • 14.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 14.4.1. Poly-L-Lactic Acid (PLLA)
    • 14.4.2. Tyrosine-derived Polycarbonate
    • 14.4.3. Others (Polydioxanone, etc.)
  • 14.5. Market Value Forecast, by End-user, 2017 - 2031
    • 14.5.1. Hospital
    • 14.5.2. Ambulatory Surgical Center
    • 14.5.3. Cardiac Catheterization Lab
    • 14.5.4. Others (Research Institute, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Disease Type
    • 14.7.3. By Material Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017 - 2031
    • 15.2.1. Everolimus-eluting Device
    • 15.2.2. Novolimus-eluting Device
    • 15.2.3. Sirolimus-eluting Device
    • 15.2.4. Others (Rapamycin, etc.)
  • 15.3. Market Value Forecast, by Disease Type, 2017 - 2031
    • 15.3.1. Coronary Artery Disease
    • 15.3.2. Peripheral Artery Disease
  • 15.4. Market Value Forecast, by Material Type, 2017 - 2031
    • 15.4.1. Poly-L-Lactic Acid (PLLA)
    • 15.4.2. Tyrosine-derived Polycarbonate
    • 15.4.3. Others (Polydioxanone, etc.)
  • 15.5. Market Value Forecast, by End-user, 2017 - 2031
    • 15.5.1. Hospital
    • 15.5.2. Ambulatory Surgical Center
    • 15.5.3. Cardiac Catheterization Lab
    • 15.5.4. Others (Research Institute, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Disease Type
    • 15.7.3. By Material Type
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. Kyoto Medical Planning Co., Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Test Type Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. BIOTRONIK Group of Companies
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Test Type Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. REVA Medical
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Test Type Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Elixir Medical
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Test Type Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Arterius
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Test Type Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Meril Life Sciences Pvt. Ltd
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Test Type Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. S3V Vascular Technologies
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Test Type Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Zorion medical
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Test Type Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Medtronic (development phase)
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Test Type Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 03: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 04: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 09: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 10: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 14: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 15: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 19: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 20: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 24: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 25: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 29: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
  • Table 30: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 03: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 04: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 05: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 06: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 07: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 08: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 09: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 10: Global Bioresorbable Vascular Scaffold Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 11: Global Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 12: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 13: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 15: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 16: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 17: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 18: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 19: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 20: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 21: North America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 22: North America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 23: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 25: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 26: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 27: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 28: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 29: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 30: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 31: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 32: Europe Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Europe Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 38: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 39: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 40: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 41: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 42: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 43: Asia Pacific Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 44: Asia Pacific Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 46: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 48: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 49: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 50: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 51: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 52: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 53: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 54: Latin America Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 55: Latin America Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 56: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 59: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 60: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 62: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 63: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by Material Type, 2022 and 2031
  • Figure 64: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by Material Type, 2023-2031
  • Figure 65: Middle East & Africa Bioresorbable Vascular Scaffold Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 66: Middle East & Africa Bioresorbable Vascular Scaffold Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 67: Global Bioresorbable Vascular Scaffold Market Share Analysis, by Company, 2022